Related Experiment Videos
The global epidemic of atherosclerotic cardiovascular disease
Salim Yusuf1, Stephanie Ounpuu, Sonia Anand
1Population Health Research Institute and Division of Cardiology, McMaster University, Hamilton, Ont., Canada. yusufs@fhs.mcmaster.ca
Insights
Cardiovascular diseases are a growing global health crisis, particularly in developing nations. Addressing this requires integrated strategies focusing on prevention, clinical care, and societal changes like tobacco control and promoting healthy lifestyles.
Area of Science:
- Global Health
- Epidemiology
- Cardiovascular Medicine
Background:
- Cardiovascular diseases (CVDs) represent a significant and growing cause of mortality worldwide.
- Developing countries bear a disproportionate burden, with projections indicating 80-90% of CVDs will occur in low- and middle-income countries by 2025.
- The rise in CVDs is attributed to factors including increased longevity, urbanization, rising obesity, and global tobacco use.
Purpose of the Study:
- To highlight the escalating global burden of cardiovascular diseases, especially in developing nations.
- To identify key drivers contributing to the projected increase in CVDs.
- To emphasize the need for comprehensive strategies to combat the CVD epidemic.
Main Methods:
- Analysis of global mortality data and disease burden trends.
- Identification of demographic and societal factors influencing cardiovascular disease prevalence.
- Review of current public health challenges and policy recommendations.
Main Results:
- Developing countries face a substantial and increasing burden of cardiovascular diseases.
- A 'double burden of disease' exists in many regions, with co-existing infections, nutritional disorders, and chronic non-communicable diseases.
- Projected increases in CVDs are linked to demographic shifts and lifestyle changes.
Conclusions:
- Combating the projected global CVD epidemic requires multifaceted policies.
- Effective strategies must integrate prevention, clinical care, and resource allocation for individual and community-level interventions.
- Societal-level changes, including tobacco control and promotion of physical activity and nutrition, are crucial.
Abstract:
Of the 50 million deaths that occur in the world, 40 million occur in developing countries. Already a substantial proportion of these deaths are due to cardiovascular diseases. It is projected that by the year 2025 well over 80-90% of all the cardiovascular diseases in the world will be occurring in low income and middle income countries. This increase in cardiovascular disease is due to a number of causes which include the following: (1) conquest of deaths in childhood and infancy from nutritional deficiencies and infection; (2) urbanization with increasing levels of obesity; (3) increasing longevity of the population so that a higher proportion of individuals reach the age when they are subject to chronic diseases, and (4) increasing use of tobacco worldwide. In most countries in the world other than those in the West, the burden of disease is still due to a combination of infections and nutritional disorders as well as those due to chronic diseases. This double burden of disease poses a challenge that is not only medical and epidemiological, but also social and political. Tackling this projected global epidemic of cardiovascular disease therefore needs policies that combine sound knowledge of prevention, good clinical care, but also deals with the allocation of resources for both individual level and community level preventive strategies. The former involves dealing with high-risk individuals through appropriate medical and therapeutic interventions. The latter involves societal level changes including laws that curb the use of tobacco, and strategies that promote physical activities, and appropriate nutrition.
Related Concept Videos
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology